Bone Abstracts (2014) 3 OP7 | DOI: 10.1530/boneabs.3.PP357

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Jacques P Brown, Michael A Bolognese, Pei-Ran Ho, Christian Roux, Henry G Bone, Sydney L Bonnick, Joop van den Bergh, Irene Ferreira, Prayashi Ghelani, Paula Dakin, Rachel B Wagman & Christopher Recknor

see PP357.